UBS Group
PROK icon

UBS Group’s ProKidney PROK Stock Holding History

UBS Group’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$599K Sell
334,546
-81,993
-20% -$174K ﹤0.01% 5951
2025
Q4 		$933K Sell
416,539
-91,814
-18% -$241K ﹤0.01% 5639
2025
Q3 		$1.23M Buy
508,353
+33,306
+7% +$88.7K ﹤0.01% 5383
2025
Q2 		$281K Buy
475,047
+226,617
+91% +$176K ﹤0.01% 6487
2025
Q1 		$218K Sell
248,430
-9,789
-4% -$13.6K ﹤0.01% 6493
2024
Q4 		$436K Buy
258,219
+207,140
+406% +$373K ﹤0.01% 5942
2024
Q3 		$98.1K Buy
51,079
+26,274
+106% +$59.6K ﹤0.01% 6389
2024
Q2 		$61K Sell
24,805
-26,208
-51% -$70.4K ﹤0.01% 6537
2024
Q1 		$83.7K Buy
51,013
+2,694
+6% +$3.96K ﹤0.01% 6301
2023
Q4 		$86K Buy
48,319
+12,067
+33% +$25.9K ﹤0.01% 6261
2023
Q3 		$166K Sell
36,252
-4,345
-11% -$41.6K ﹤0.01% 5493
2023
Q2 		$454K Buy
40,597
+35,388
+679% +$377K ﹤0.01% 4902
2023
Q1 		$59K Buy
5,209
+2,571
+97% +$27.4K ﹤0.01% 6323
2022
Q4 		$18.1K Buy
2,638
+1,845
+233% +$17.6K ﹤0.01% 7767
2022
Q3 		$7K Sell
793
-713
-47% -$6.2K ﹤0.01% 8894
2022
Q2 		$15K Buy
+1,506
New +$14.9K ﹤0.01% 7309
2022
Q1 		– Sell
-755
Closed -$7K – 10756
2021
Q4 		$7K Buy
+755
New +$7.46K ﹤0.01% 9161

Other funds holding PROK

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $499M AUM 186.05% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

UBS Group's PROK Position: Q1 2026 in Review

UBS Group reduced its ProKidney (PROK) stake by 20% in Q1 2026, selling an estimated $174K and leaving 334,546 shares worth $599K. The position accounts for ﹤0.01% of the portfolio, ranked #5951.

UBS Group first reported a position in PROK in Q4 2021 and has held it in 17 quarters since. The position peaked at $1.23M in Q3 2025. 71 funds tracked by Wall St. Rank hold PROK as of Q1 2026.

  • UBS Group held 334,546 shares of ProKidney worth $599K as of Q1 2026.
  • UBS Group sold 81,993 ProKidney shares in Q1 2026, an estimated $174K.
  • ProKidney made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #5951 holding.
  • UBS Group first reported a position in ProKidney in Q4 2021 and has held it in 17 quarters since.
  • UBS Group's ProKidney position peaked at $1.23M in Q3 2025.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.